Peptide Therapeutics for Breast Cancer

About this Study

A newly found peptide that can kill tumor cells while sparing healthy cells could be an effective therapeutic strategy, when combined with other drugs, for drug-resistant cancers such as breast cancer, according to the study, “published in the latest edition of the journal Oncotarget According to the research literature and the National Institutes of Health (NIH) , peptide therapeutics are considered promising for the advancement of breast cancer drug target development. Peptides are part of the building blocks of protein structure and consist of one or two bonded amino acids in a chain. The structural templates of the building blocks can be manipulated in the laboratory to develop peptides that play a therapeutic role in fighting disease such as breast cancer. Challenges in the field of peptide therapeutics include improving delivery modalities that specifically target a patient’s tumor — and understanding the potential safety and toxicity risks associated with the novel treatment.Researchers from the A*STAR Bioprocessing Technology Institute, in Singapore, found that a segment of the hexamethylen